“I am privileged to be a founder or lead investor for several ophthalmic companies that have made important advancements in patient care, including AMO, Chiron Vision, IntraLase, and eyeonics. As a founding investor, I believe that Glaukos has developed a technology for the ophthalmic surgeon that significantly improves the management of glaucoma. I am excited to be a part of this emerging company."
William J. Link, PhD
Chairman of the Board, Glaukos Corporation
Managing Director, Versant Ventures
Invested in Preserving Vision
The healthcare venture capital community invests in biotechnology, pharmaceutical, and medical device companies that have clear competitive advantages, addressable and large unmet market needs, broad intellectual property protection, and a proven leadership team. Glaukos Corporation is a privately-held, venture capital–funded company. To date, Glaukos has raised approximately $100 million. The majority of our funding is invested in research and development and clinical trials.